CV Sciences, Inc. (CVSI)

0.0397 +0.0017 (+4.61%) At close: 03:25PM EDT

CV Sciences, Inc.

9530 Padgett Street
Suite 107
San Diego, CA 92126
United States
866 290 2157
https://www.cvsciences.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 42

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Joseph D. Dowling	CEO, Secretary & Director	313.07k	N/A	1957
Mr. Joerg Grasser	Chief Financial Officer	228k	N/A	1975
Mr. Tim Hitchman	Vice President of Operations	N/A	N/A	N/A
Mr. Jesse Karagianes	Senior Vice President of Revenue Growth	N/A	N/A	N/A
Ms. Alyssa Dunn	Operations Manager	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Corporate Governance

CV Sciences, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.